logo
Burberry to Cut 1,700 Jobs in Turnaround Push

Burberry to Cut 1,700 Jobs in Turnaround Push

New York Times14-05-2025
Burberry, the British fashion brand known for its trench coats and signature checkered print, said on Wednesday that it would slash up to 1,700 jobs in a bid to cut costs as it tries to return to profit after a period of poor sales in an increasingly volatile luxury sector.
The job cuts, which represent 18 percent of the company's global work force, are part of larger organizational changes that are expected to save the company 60 million pounds. The measures come amid global uncertainty that increased after President Trump imposed tariffs on America's top trading partners.
'The current macroeconomic environment has become more uncertain in light of geopolitical developments,' the company said in a statement.
The company announced the cost-cutting strategy after reporting a 117 percent drop in its annual pretax profits in the 2025 financial year, which ended March 29. Operating losses were £3 million, or $4 million, down from a £418 million, or $558 million, profit the year prior. Revenue was down 17 percent to £2.5 billion, or $3.4 billion.
Burberry has struggled in recent years after managerial and designer changes, a drive to increase prices that fell flat with customers and the wider global slowdown of luxury consumption, particularly in China, its biggest overseas market.
The company said the cost-cutting efforts, combined with earlier measures, could lead to planned savings of up to £100 million, or $133 million, by 2027. Most job losses will hit corporate offices but could also affect retail stores and factories.
Shares jumped by as much as 10 percent on the news after the market opened in London.
The company's chief executive, Joshua Shulman, joined Burberry from its American rival, Coach, last year to lead a turnaround effort. He said in a statement on Wednesday that he was 'more optimistic than ever that Burberry's best days are ahead and that we will deliver sustainable profitable growth over time,' but added that the last financial year had been challenging.
Charlie Huggins, a manager at the investment firm Wealth Club, noted that a 6 percent decline in same-store sales in the fourth quarter was 'a marked improvement' and suggested that 'the strategic plan to reignite the brand may be gaining early traction.'
'But fiscal year 2025 was still an annus horribilis for Burberry, ' he said. 'Almost everything that could go wrong did. Luxury consumers across the globe significantly tightened their belts hitting the whole luxury sector. But Burberry has seen more impact than most.'
Other groups that noted earnings declines recently include LVMH, owner of Louis Vuitton and Dior, and Kering, which owns brands like Gucci and Saint Laurent.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

PHSC Full Year 2025 Earnings: UK£0.012 loss per share (vs UK£0.022 profit in FY 2024)
PHSC Full Year 2025 Earnings: UK£0.012 loss per share (vs UK£0.022 profit in FY 2024)

Yahoo

time8 minutes ago

  • Yahoo

PHSC Full Year 2025 Earnings: UK£0.012 loss per share (vs UK£0.022 profit in FY 2024)

PHSC (LON:PHSC) Full Year 2025 Results Key Financial Results Revenue: UK£3.22m (down 15% from FY 2024). Net loss: UK£126.2k (down by 151% from UK£248.8k profit in FY 2024). UK£0.012 loss per share (down from UK£0.022 profit in FY 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period PHSC shares are down 14% from a week ago. Risk Analysis It's necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with PHSC (at least 1 which is a bit unpleasant), and understanding these should be part of your investment process. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

Carl Zeiss Meditec (ETR:AFX) shareholders have endured a 62% loss from investing in the stock three years ago
Carl Zeiss Meditec (ETR:AFX) shareholders have endured a 62% loss from investing in the stock three years ago

Yahoo

time8 minutes ago

  • Yahoo

Carl Zeiss Meditec (ETR:AFX) shareholders have endured a 62% loss from investing in the stock three years ago

If you love investing in stocks you're bound to buy some losers. Long term Carl Zeiss Meditec AG (ETR:AFX) shareholders know that all too well, since the share price is down considerably over three years. Sadly for them, the share price is down 63% in that time. Now let's have a look at the company's fundamentals, and see if the long term shareholder return has matched the performance of the underlying business. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS). During the three years that the share price fell, Carl Zeiss Meditec's earnings per share (EPS) dropped by 16% each year. This reduction in EPS is slower than the 28% annual reduction in the share price. So it seems the market was too confident about the business, in the past. The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image). Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here. A Different Perspective While the broader market gained around 23% in the last year, Carl Zeiss Meditec shareholders lost 16% (even including dividends). Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 7% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. It's always interesting to track share price performance over the longer term. But to understand Carl Zeiss Meditec better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs with Carl Zeiss Meditec , and understanding them should be part of your investment process. For those who like to find winning investments this free list of undervalued companies with recent insider purchasing, could be just the ticket. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on German exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

Trainline plc's (LON:TRN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Trainline plc's (LON:TRN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Yahoo

time38 minutes ago

  • Yahoo

Trainline plc's (LON:TRN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

It is hard to get excited after looking at Trainline's (LON:TRN) recent performance, when its stock has declined 3.6% over the past three months. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the company is worth looking at. Specifically, we decided to study Trainline's ROE in this article. Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. Put another way, it reveals the company's success at turning shareholder investments into profits. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. How To Calculate Return On Equity? The formula for return on equity is: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Trainline is: 21% = UK£58m ÷ UK£283m (Based on the trailing twelve months to February 2025). The 'return' is the income the business earned over the last year. So, this means that for every £1 of its shareholder's investments, the company generates a profit of £0.21. View our latest analysis for Trainline What Has ROE Got To Do With Earnings Growth? So far, we've learned that ROE is a measure of a company's profitability. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics. Trainline's Earnings Growth And 21% ROE To start with, Trainline's ROE looks acceptable. Especially when compared to the industry average of 8.7% the company's ROE looks pretty impressive. This probably laid the ground for Trainline's significant 71% net income growth seen over the past five years. We reckon that there could also be other factors at play here. For example, it is possible that the company's management has made some good strategic decisions, or that the company has a low payout ratio. We then compared Trainline's net income growth with the industry and we're pleased to see that the company's growth figure is higher when compared with the industry which has a growth rate of 32% in the same 5-year period. The basis for attaching value to a company is, to a great extent, tied to its earnings growth. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. What is TRN worth today? The intrinsic value infographic in our free research report helps visualize whether TRN is currently mispriced by the market. Is Trainline Making Efficient Use Of Its Profits? Trainline doesn't pay any regular dividends currently which essentially means that it has been reinvesting all of its profits into the business. This definitely contributes to the high earnings growth number that we discussed above. Conclusion In total, we are pretty happy with Trainline's performance. Specifically, we like that the company is reinvesting a huge chunk of its profits at a high rate of return. This of course has caused the company to see substantial growth in its earnings. With that said, the latest industry analyst forecasts reveal that the company's earnings growth is expected to slow down. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store